This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Lidocaine and prilocaine

Read time: 1 mins
Marketing start date: 12 Jan 2025

Summary of product characteristics


Effective Time

20241230

Version

1

Spl Product Data Elements

Lidocaine and prilocaine Lidocaine and prilocaine LIDOCAINE LIDOCAINE PRILOCAINE PRILOCAINE CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) POLYOXYL 40 HYDROGENATED CASTOR OIL SODIUM HYDROXIDE WATER off-white

Application Number

ANDA219120

Brand Name

Lidocaine and prilocaine

Generic Name

Lidocaine and prilocaine

Product Ndc

70771-1872

Product Type

HUMAN PRESCRIPTION DRUG

Route

TOPICAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1872-5 Lidocaine and Prilocaine Cream USP, 2.5%/2.5% 5 grams Rx tube-label

Spl Unclassified Section

SPL UNCLASSIFIED

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.